STOCK TITAN

Healwell AI A SUB VTG (HWAIF) Stock News, Mar-Aug 2026

HWAIF OTC

HEALWELL AI Inc. develops and commercializes healthcare artificial intelligence software for preventative care, with a focus on clinical decision support, early disease identification, and workflow tools for healthcare providers. News about HWAIF commonly covers the company’s DARWEN™ AI platform, Smart Search, Smart Summary, Smart ID, and the use of AI-enriched clinical data to support real-world evidence across disease areas.

Company updates also include revenue and Adjusted EBITDA reporting, integration of Orion Health, enterprise health-system and Health Information Exchange software contracts, customer renewals, scientific publications, conference participation, and board or governance changes. HEALWELL trades on the Toronto Stock Exchange as AIDX and on the OTCQX market as HWAIF.

Rhea-AI Summary

HEALWELL AI (TSX:AIDX, OTCQX:HWAIF) announced that its subsidiary Pentavere, developer of the DARWEN™ AI platform, has been nominated for the 2026 International Prix Galien in the Best Startup category after winning the 2024 Prix Galien USA Award for Best Digital Health Startup.

The International Prix Galien is held every two years and gathers prior national and regional winners, with 2026 nominees including major global pharmaceutical and medical technology companies. DARWEN™ analyzes complex clinical information into structured, traceable evidence and has been applied across multiple therapeutic areas. HEALWELL has integrated DARWEN™ across its healthcare technology ecosystem, including Orion Health, to leverage shared AI intellectual property across products, diseases and geographies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.71%
Tags
AI
-
Rhea-AI Summary

HEALWELL (OTCQX:HWAIF) reported Q2-2026 revenue from continuing operations of $33.0 million, broadly flat versus $33.2 million in Q2-2025 as prior-year one-time professional services did not recur. Gross profit was $17.9 million with a 54% margin versus 56% a year earlier, and Q2 Adjusted EBITDA was $1.1 million, down from $2.3 million.

For the first half of 2026, revenue rose 60% to $66.2 million, gross profit increased 62% to $37.4 million, and Adjusted EBITDA improved to $1.9 million from $0.1 million. Operating cash flow turned positive at $4.5 million versus a $9.9 million outflow, and IFRS net loss from continuing operations narrowed to $0.45 million. HEALWELL reported Q2 IFRS net income from continuing operations of $6.4 million versus a $4.1 million loss in Q2-2025, partly reflecting fair value changes.

The company’s indirect interest in SpaceX was valued at approximately CAD$23 million as of June 30, 2026, versus a CAD$4.6 million carrying value at March 31, 2026. HEALWELL plans to monetize this position after the lock-up to further strengthen liquidity. Subscription, Support and Maintenance revenue grew 4% year-over-year in Q2 and 76% for the first half, driven largely by the Orion Health acquisition and AI cross-sell initiatives, as the company targets an approximately 10% Adjusted EBITDA margin by year-end 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.00%
Tags
-
Rhea-AI Summary

HEALWELL AI (TSX:AIDX, OTCQX:HWAIF) will release its fiscal second quarter 2026 financial results for the period ended June 30, 2026 after market close on Thursday, August 6, 2026. Management will discuss the results on a conference call and simultaneous webcast on Friday, August 7, 2026 at 8:30 a.m. ET (5:30 a.m. PT), hosted by CEO James Lee, President Dr. Alexander Dobranowski and CFO Anthony Lam.

Investors can access the webcast at https://bit.ly/AIDX-Q2, or join by phone via North American toll-free (+1) 800 431 2204 or Toronto/local and international (+1) 289 514 5015, dialing in 10 minutes early and requesting the “HEALWELL AI Inc. Conference Call.” The company is a healthcare artificial intelligence business focused on preventative care and advanced clinical decision support systems.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
conferences earnings AI
Rhea-AI Summary

HEALWELL AI (OTCQX:HWAIF, TSX:AIDX) reported voting results from its June 25, 2026 annual general and special meeting. Shareholders holding about 66.83% of eligible votes were represented. All resolutions passed, including fixing the board at seven, re-electing all directors, reappointing Deloitte, and re-approving the 10% rolling equity incentive plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.88%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX:HWAIF) reported completion of a multi-province pilot of its DARWEN-powered SMART Summary and SMART Search AI tools across British Columbia, Ontario and New Brunswick, with results accepted for presentation at the AMIA 2026 Annual Symposium in Dallas.

The company also updated investors on its indirect SpaceX stake, estimating its value at about CAD$25 million following the SpaceX IPO, and outlined IFRS treatment of a $30 million convertible debenture maturing December 31, 2029, while stating it remains in compliance with debt covenants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
AI
-
Rhea-AI Summary

HEALWELL (OTCQX:HWAIF) reported Q1-2026 revenue from continuing operations of $33.2M, up 316% year‑over‑year, driven by the Orion Health acquisition and AI division growth. Gross profit was $19.5M (59% margin). Adjusted EBITDA was positive $0.7M; IFRS net loss was $6.8M. Cash was $21.9M as of March 31, 2026.

Business highlights included a Middle East governmental AI contract, a multi‑million dollar U.S. HIE deal, launch of WELLTRUST™, and DARWEN™ reaching 47 peer‑reviewed publications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
none
Rhea-AI Summary

HEALWELL AI (TSX:AIDX | OTCQX:HWAIF) will release Fiscal Q1 2026 results for the period ended March 31, 2026, after market close on Thursday, May 7, 2026. The company will host a conference call and simultaneous webcast on Friday, May 8, 2026 at 8:30 AM ET / 5:30 AM PT.

The call will be led by James Lee (CEO), Dr. Alexander Dobranowski (President) and Anthony Lam (CFO). Webcast and dial-in details are provided for live access.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
conferences earnings AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) appointed Brad Porter to its Board of Directors effective April 22, 2026, strengthening commercial and strategic leadership.

Porter, HEALWELL chief commercial officer and CEO of Orion Health, brings over 15 years of finance and global healthcare technology experience. Ian McCrae is stepping down after the Orion Health integration.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
management AI
-
Rhea-AI Summary

HEALWELL (OTCQX:HWAIF) will present at the 2026 Bloom Burton & Co. Healthcare Investor Conference in Toronto on April 21-22, 2026. Presentation: April 22, 2026, 2:00–2:30 PM ET. CEO James Lee and President Dr. Alexander Dobranowski will attend and hold one-on-one investor meetings.

The company will deliver a corporate presentation and take part in 1-on-1 meetings; investors should contact Bloom Burton representatives to schedule meetings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.51%
Tags
none
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) reported record fiscal 2025 results with $103.8M revenue, a 427% increase year-over-year, and its first full year of positive Adjusted EBITDA at $2.3M. The company reported an IFRS net loss of $39.1M and ended the year with $18.6M cash.

HEALWELL completed strategic divestments generating $9.7M in cash, integrated Orion Health, and highlighted DARWEN's scientific validation with 47 peer-reviewed publications.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.94%
Tags
AI

FAQ

What is the current stock price of Healwell AI A SUB VTG (HWAIF)?

Healwell AI A SUB VTG (HWAIF) last closed at $0.3924.

What is the market cap of Healwell AI A SUB VTG (HWAIF)?

The market cap of Healwell AI A SUB VTG (HWAIF) is approximately $131.2M.